G protein-coupled receptors (GPCRs) play a central role in the pathogenesis and development of osteoporosis, a serious bone metabolism-related disease.

Domain Therapeutics ("Domain" or "the Company"), the GPCR experts harnessing deep receptor biology to develop breakthrough treatments for patients, today announces new clinical and preclinical data ...